413 related articles for article (PubMed ID: 35565273)
1. The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery.
Bae J; Choi YS; Cho G; Jang SJ
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565273
[TBL] [Abstract][Full Text] [Related]
2. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
Qu J; Kalyani FS; Liu L; Cheng T; Chen L
Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
[TBL] [Abstract][Full Text] [Related]
3. Organoid Models for Precision Cancer Immunotherapy.
Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
Front Immunol; 2022; 13():770465. PubMed ID: 35450073
[TBL] [Abstract][Full Text] [Related]
4. Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy.
Wang J; Chen C; Wang L; Xie M; Ge X; Wu S; He Y; Mou X; Ye C; Sun Y
Front Oncol; 2022; 12():872531. PubMed ID: 35449581
[TBL] [Abstract][Full Text] [Related]
5. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
6. The promises and challenges of patient-derived tumor organoids in drug development and precision oncology.
Granat LM; Kambhampati O; Klosek S; Niedzwecki B; Parsa K; Zhang D
Animal Model Exp Med; 2019 Sep; 2(3):150-161. PubMed ID: 31773090
[TBL] [Abstract][Full Text] [Related]
7. Promises and Challenges of Organoid-Guided Precision Medicine.
Bose S; Clevers H; Shen X
Med; 2021 Sep; 2(9):1011-1026. PubMed ID: 34617071
[TBL] [Abstract][Full Text] [Related]
8. Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer.
Haque MR; Rempert TH; Al-Hilal TA; Wang C; Bhushan A; Bishehsari F
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503294
[TBL] [Abstract][Full Text] [Related]
9. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).
Cao J; Chan WC; Chow MSS
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35322860
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived organoids as a model for tumor research.
Wang J; Feng X; Li Z; Chen Y; Huang W
Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
[TBL] [Abstract][Full Text] [Related]
12. Organoid technology in female reproductive biomedicine.
Heidari-Khoei H; Esfandiari F; Hajari MA; Ghorbaninejad Z; Piryaei A; Baharvand H
Reprod Biol Endocrinol; 2020 Jun; 18(1):64. PubMed ID: 32552764
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response.
Piro G; Agostini A; Larghi A; Quero G; Carbone C; Esposito A; Rizzatti G; Attili F; Alfieri S; Costamagna G; Tortora G
Front Med (Lausanne); 2021; 8():793144. PubMed ID: 35004765
[TBL] [Abstract][Full Text] [Related]
14. Urological cancer organoids, patients' avatars for precision medicine: past, present and future.
Chen H; Zhang W; Maskey N; Yang F; Zheng Z; Li C; Wang R; Wu P; Mao S; Zhang J; Yan Y; Li W; Yao X
Cell Biosci; 2022 Aug; 12(1):132. PubMed ID: 35986387
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived organoid (PDO) platforms to facilitate clinical decision making.
Liu L; Yu L; Li Z; Li W; Huang W
J Transl Med; 2021 Jan; 19(1):40. PubMed ID: 33478472
[TBL] [Abstract][Full Text] [Related]
16. Organoid technology and applications in cancer research.
Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
[TBL] [Abstract][Full Text] [Related]
17. Application of Patient-Derived Cancer Organoids to Personalized Medicine.
Shiihara M; Furukawa T
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629212
[TBL] [Abstract][Full Text] [Related]
18. Organoid technology in cancer precision medicine.
Xia X; Li F; He J; Aji R; Gao D
Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
[TBL] [Abstract][Full Text] [Related]
19. Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications.
Castiglione H; Vigneron PA; Baquerre C; Yates F; Rontard J; Honegger T
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365119
[TBL] [Abstract][Full Text] [Related]
20. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
